Given that MBP autoantibodies are implicated in demyelinating disorders such as multiple sclerosis [87,88] and often arise following more severe CNS insults [51,89,90], this absence suggests that repetitive low-level blast exposures may not produce the same extent of myelin injury as higher-intensity blasts [53,91,92,93]. The gene discussed is MBP; the disease is demyelinating disease.